SEC Form 3 · accession 0001144204-15-000025
Akari Therapeutics Plc · AKTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gur Roshwalb
Officer — Chief Executive Officer · Director
Period of report
Jan 1, 2015
Accepted (ET)
Jan 2, 2015 · 6:17 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001541157
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | holding | — | — | — | 175,438 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Purchase Ordinary SharesF1 | $2.00 | holding | — | — | — | Sep 24, 2014 | Sep 24, 2023 | Ordinary Shares | 660,000 | — | D |
| Options to Purchase Ordinary SharesF2 | $0.75 | holding | — | — | — | May 31, 2014 | Feb 5, 2024 | Ordinary Shares | 120,000 | — | D |
Explanation of responses
- F125% of the shares underlying the options vest annually beginning on 9/24/2014.
- F2100% of the shares underlying the options vested on 5/31/2014.
Remarks
The Reporting Person is filing this form in connection with the Issuer transitioning from foreign private issuer to full reporting status as of January 1, 2015. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents ten (10) Ordinary Shares. Exhibit List - Exhibit 24 Power of Attorney.